Individuals with type 2 diabetes have typical abnormalities in the metabolism of intestinally generated lipoprotein even when taking statin medication, according to very recent state-of-the art analysis of the kinetics of lipoproteins containing apoB48. This evidence concerns the gene APOB and type 2 diabetes mellitus.